Filter
827
Text search:
dosing
Featured
Recommendations
116
New Publications
224
Language
Document type
No document type
465
Guidelines
181
Studies & Reports
93
Manuals
29
Training Material
21
Fact sheets
16
Strategic & Response Plan
12
Situation Updates
4
Resource Platforms
2
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
India
46
South Africa
35
Kenya
27
Tanzania
23
Global
19
Ethiopia
17
Zambia
15
Uganda
11
Nepal
10
Africa
10
Sierra Leone
9
Rwanda
9
Western and Central Europe
9
Nigeria
8
Ghana
8
Malawi
8
Namibia
8
Bangladesh
7
Myanmar / Burma
7
Liberia
6
Zimbabwe
6
Philippines
6
West and Central Africa
5
USA
4
Haiti
4
Syria
4
Cambodia
4
Latin America and the Carribbean
4
Congo, Democratic Republic of
3
South Sudan
3
Argentina
3
Eswatini/ Swaziland
3
Lesotho
3
Burkina Faso
2
Germany
2
Indonesia
2
Ukraine
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
United Kingdom
2
Guinea
1
Senegal
1
Mali
1
Guinea-Bissau
1
Cameroon
1
Pakistan
1
Iraq
1
Gambia
1
Sudan
1
Benin
1
Peru
1
Brazil
1
Botswana
1
Angola
1
Yemen
1
East and Southern Africa
1
Middle East and North Africa
1
Venezuela
1
Eastern Europe
1
Albania
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Georgia
1
North America
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
266
Clinical Guidelines
169
Women & Child Health
49
Public Health
28
Capacity Building
26
Key Resources
19
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
HIV
114
TB
87
AMR
66
COVID-19
42
Pharmacy
36
Mental Health
32
NCDs
22
NTDs
19
Ebola
14
Caregiver
14
Cholera
9
Conflict
8
Rapid Response
7
Refugee
6
Planetary Health
6
Polio
2
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Natural Hazards
1
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy of “re-purposed” drugs that have been widely used to treat other infections but are al
...
WHO Secretariat Information paper July 2016
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘
...
The target audience for this guideline is primarily for health care providers nurses, doctors, social workers and other people involved in HIV response in Rwanda so that they are capable of offering quality care services to patients over a long time. The new National Guidelines for Prevention and Ma
...
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-
...
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions.
The previous edition of the drugs chart is also av
...
Standard treatment guidelines
recommended
Standard Treatment Guideline
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br
...
Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public
health hazard often faced by rural population in tropical and subtropical countries with heavy
rainfall and humid climate.
The following information provides guidance to health care providers attending to the medical needs of HIV-infected adults (including pregnant women) or children displaced from disaster areas who have not yet secured HIV care in the areas where they have relocated.
(*)
- HHS Panel on Antiretrov
...
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Standard Treatment Guideline
